Sun Pharma presents follow-up data from ILUMYA Phase 3 reSURFACE 1 and 2 trials
Additional data show people with and without metabolic syndrome respond similarly to ILUMYA treatment with comparable, positive…
Recover your password.
A password will be e-mailed to you.